Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination
International Immunopharmacology · 2024-01 · 127 · 111408
DOI: 10.1016/j.intimp.2023.111408 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-01. Verfasst von Dan-Jie Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Medicine and Neurobiology, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, Ch…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis, Isoquinolines, Benzophenanthridines. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Shanghai Medical College, Fudan University, Shanghai Key Laboratory of Acupuncture Mechanism and Acupoint Function, National Natural Science Foundation of China.
Abstract (Originalsprache)
Microglia aggregate in regions of active inflammation and demyelination in the CNS of multiple sclerosis (MS) patients and are considered pivotal in the disease process. Targeting microglia is a promising therapeutic approach for myelin repair. Previously, we identified two candidates for microglial modulation and remyelination using a Connectivity Map (CMAP)-based screening strategy. Interestingly, with results that overlapped, sanguinarine (SAN) emerged as a potential drug candidate to modulate microglial polarization and promote remyelination. In the current study, we demonstrate the efficacy of SAN in mitigating the MS-like experimental autoimmune encephalomyelitis (EAE) in a dose-dependent manner. Meanwhile, prophylactic administration of a medium dose (2.5 mg/kg) significantly reduces disease incidence and ameliorates clinical signs in EAE mice. At the cellular level, SAN reduces the accumulation of microglia in the spinal cord. Morphological analyses and immunophenotyping reveal a less activated state of microglia following SAN administration, supported by decreased inflammatory cytokine production in the spinal cord. Mechanistically, SAN skews primary microglia towards an immunoregulatory state and mitigates proinflammatory response through PPARγ activation. This creates a favorable milieu for the differentiation of oligodendrocyte progenitor cells (OPCs) when OPCs are incubated with conditioned medium from SAN-treated microglia. We further extend our investigation into the cuprizone-induced demyelinating model, confirming that SAN treatment upregulates oligodendrocyte lineage genes and increases myelin content, further suggesting its pro-myelination effect. In conclusion, our data propose SAN as a promising candidate adding to the preclinical therapeutic arsenal for regulating microglial function and promoting myelin repair in CNS demyelinating diseases such as MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Medicine and Neurobiology, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Department of Integrative Medicine and Neurobiology, School of Basic Medical Science, Shanghai Medical College, Fudan University, Shanghai 200032, China; State Key Laboratory of Medical Neurobiology and MOE Frontiers Ce…
- Department of Anatomy, Histology and Embryology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Department of Clinical Neuroscience, Karolinska Institute, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. Electronic address: keying.zhu@ki.se.
Förderung
- Shanghai Medical College, Fudan University
- Shanghai Key Laboratory of Acupuncture Mechanism and Acupoint Function
- National Natural Science Foundation of China
- Innovative Research Team of High-level Local Universities in Shanghai
- China Scholarship Council
- National Key Research and Development Program of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Wang, D. J., Wang, X., Li, S. L., Zhang, T. T., Yang, Y. C., Wang, Y. M., Zhao, X. Q., Li, K. Y., Wang, Y. Q., Li, Y., Zhu, K. Y., & Wang, J. (2024). Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination. International Immunopharmacology, 127, 111408. https://doi.org/10.1016/j.intimp.2023.111408
Vancouver
Wang DJ, Wang X, Li SL, Zhang TT, Yang YC, Wang YM, et al. Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination. International Immunopharmacology. 2024;127:111408. doi:10.1016/j.intimp.2023.111408
BibTeX
@article{Wang2024,
author = {Wang, Dan-Jie and Wang, Xiao and Li, Shu-le and Zhang, Tong-Tong and Yang, Ya-Chen and Wang, Yu-Meng and Zhao, Xiao-Qiang and Li, Kun-Yu and Wang, Yan-Qing and Li, Yan and Zhu, Ke-Ying and Wang, Jun},
title = {Sanguinarine modulates microglial function via PPARγ activation and protects against CNS demyelination},
journal = {International Immunopharmacology},
year = {2024},
volume = {127},
pages = {111408},
doi = {10.1016/j.intimp.2023.111408}
}
EUVIMED